ArticleCureus2025
Rapidly Progressive Dementia After Platelet-Rich Plasma Therapy: A Case of Sporadic Creutzfeldt-Jakob Disease in the Context of Chronic Ehrlichiosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prion diseases are fatal neurological disorders characterized by the accumulation of abnormal proteins in the central nervous system, leading to rapid neurodegeneration. We present a male his 70s who developed rapidly progressive dementia three weeks after a routine platelet-rich plasma (PRP) injection for chronic hip pain. MRI revealed multifocal cortical diffusion restriction involving the basal ganglia. CSF analysis via real-time quaking-induced conversion (RT-QuIC) confirmed prion disease, with elevated T-tau and 14-3-3 gamma proteins. He also tested seropositive for Ehrlichia, though other infectious causes were ruled out. Despite treatment with IV immunoglobulins (IGs) and antibiotics, his condition declined with worsening myoclonus and hyperreflexia. He died one week after discharge to hospice, six weeks after symptom onset. This case demonstrates several classic clinical features of sporadic Creutzfeldt-Jacob disease (sCJD) and raises the possibility that an acute inflammatory response from PRP injection may have triggered sCJD in the setting of a pre-existing chronic inflammatory state from tick-borne infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.